| Primary |
| Product Used For Unknown Indication |
56.3% |
| Depression |
18.4% |
| Anxiety |
4.6% |
| Hypertension |
4.6% |
| Hypothyroidism |
4.6% |
| Prophylaxis Of Neural Tube Defect |
3.4% |
| Anxiety Disorder |
1.1% |
| Arthralgia |
1.1% |
| Drug Dependence |
1.1% |
| Mood Altered |
1.1% |
| Sleep Disorder |
1.1% |
| Thrombosis |
1.1% |
| Weight Increased |
1.1% |
|
| Inappropriate Antidiuretic Hormone Secretion |
12.1% |
| Liver Disorder |
12.1% |
| Circulatory Collapse |
9.1% |
| Exposure During Pregnancy |
6.1% |
| Infantile Apnoeic Attack |
6.1% |
| Small For Dates Baby |
6.1% |
| Ventricular Fibrillation |
6.1% |
| Ventricular Tachycardia |
6.1% |
| Bone Marrow Failure |
3.0% |
| Cytogenetic Abnormality |
3.0% |
| Electrocardiogram Qt Prolonged |
3.0% |
| Hyponatraemia |
3.0% |
| Pyloric Stenosis |
3.0% |
| Renal Aplasia |
3.0% |
| Restless Legs Syndrome |
3.0% |
| Syncope |
3.0% |
| Thrombocytopenia |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Uterine Cyst |
3.0% |
| Weight Increased |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
68.8% |
| Depression |
6.6% |
| Ill-defined Disorder |
3.7% |
| Atrial Fibrillation |
1.8% |
| Sleep Disorder |
1.8% |
| Angiotensin Converting Enzyme |
1.5% |
| Anxiety |
1.5% |
| Cardiac Disorder |
1.5% |
| Cerebrovascular Accident Prophylaxis |
1.5% |
| Delusion |
1.5% |
| Gastrointestinal Disorder |
1.5% |
| Hypertension |
1.5% |
| Thyroid Disorder |
1.5% |
| Psychotic Disorder |
1.1% |
| Anxiety Disorder |
0.7% |
| Cardiac Failure |
0.7% |
| Parkinson's Disease |
0.7% |
| Pruritus |
0.7% |
| Tachycardia |
0.7% |
| Weight Increased |
0.7% |
|
| Circulatory Collapse |
12.5% |
| Completed Suicide |
12.5% |
| Weight Increased |
10.4% |
| Suicide Attempt |
8.3% |
| General Physical Health Deterioration |
6.3% |
| Hyponatraemia |
6.3% |
| Restless Legs Syndrome |
6.3% |
| Cardiac Arrest |
4.2% |
| Nightmare |
4.2% |
| Pemphigoid |
4.2% |
| Pulmonary Embolism |
4.2% |
| Sedation |
4.2% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Fall |
2.1% |
| Lipase Increased |
2.1% |
| Multiple Drug Overdose |
2.1% |
| Myalgia |
2.1% |
| Pain In Extremity |
2.1% |
| Renal Failure Chronic |
2.1% |
| Rhabdomyolysis |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.2% |
| Depression |
11.7% |
| Hypertension |
8.8% |
| Pain |
4.8% |
| Rheumatoid Arthritis |
4.2% |
| Epilepsy |
2.9% |
| Psychotic Disorder |
2.9% |
| B-cell Lymphoma |
2.6% |
| Atrial Fibrillation |
2.2% |
| Crohn's Disease |
2.2% |
| Bipolar Disorder |
1.8% |
| Memory Impairment |
1.8% |
| Multiple Sclerosis |
1.6% |
| Schizophrenia |
1.5% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Major Depression |
1.3% |
| Osteoporosis |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Relapsing-remitting Multiple Sclerosis |
1.3% |
| Sleep Disorder |
1.3% |
|
| Pneumonia |
10.0% |
| Syncope |
7.5% |
| Atrial Flutter |
6.3% |
| Death |
6.3% |
| Progressive Multifocal Leukoencephalopathy |
6.3% |
| Weight Decreased |
6.3% |
| Drug Ineffective |
5.0% |
| Pulmonary Embolism |
5.0% |
| Sepsis |
5.0% |
| Urinary Retention |
5.0% |
| Urinary Tract Infection |
5.0% |
| Visual Acuity Reduced |
5.0% |
| Hypokalaemia |
3.8% |
| Restlessness |
3.8% |
| Sudden Cardiac Death |
3.8% |
| Tinnitus |
3.8% |
| Tremor |
3.8% |
| Visual Impairment |
3.8% |
| Atrial Fibrillation |
2.5% |
| Breast Discharge |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Potentiating Drug Interaction |
40.0% |
| Drug Interaction |
20.0% |
| Renal Failure |
20.0% |
| Urinary Retention |
20.0% |
|
